BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 29489077)

  • 1. Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
    Kruse JL; Congdon E; Olmstead R; Njau S; Breen EC; Narr KL; Espinoza R; Irwin MR
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study
    Carlier A; Berkhof JG; Rozing M; Bouckaert F; Sienaert P; Eikelenboom P; Veerhuis R; Vandenbulcke M; Berkhof J; Stek ML; Rhebergen D; Dols A; Exel EV
    J Affect Disord; 2019 Sep; 256():509-516. PubMed ID: 31279250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
    Jha MK; Wilkinson ST; Krishnan K; Collins KA; Sanacora G; Murrough J; Goes F; Altinay M; Aloysi A; Asghar-Ali A; Barnett B; Chang L; Costi S; Malone D; Nikayin S; Nissen SE; Ostroff R; Reti I; Wolski K; Wang D; Hu B; Mathew SJ; Anand A
    JAMA Netw Open; 2024 Jun; 7(6):e2417786. PubMed ID: 38916891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
    Järventausta K; Sorri A; Kampman O; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E; Peltola J; Lehtimäki K
    Acta Psychiatr Scand; 2017 Jan; 135(1):87-92. PubMed ID: 27858966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.
    Rush G; O'Donovan A; Nagle L; Conway C; McCrohan A; O'Farrelly C; Lucey JV; Malone KM
    J Affect Disord; 2016 Nov; 205():60-68. PubMed ID: 27414954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Maudsley Staging Method as predictor of electroconvulsive therapy effectiveness in depression.
    van Diermen L; Hebbrecht K; Schrijvers D; Sabbe BCG; Fransen E; Birkenhäger TK
    Acta Psychiatr Scand; 2018 Dec; 138(6):605-614. PubMed ID: 30270433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Apr; 8(4):e00933. PubMed ID: 29670819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.
    Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Sartorius A
    World J Biol Psychiatry; 2018 Aug; 19(5):379-389. PubMed ID: 28714751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression.
    Rotter A; Biermann T; Stark C; Decker A; Demling J; Zimmermann R; Sperling W; Kornhuber J; Henkel A
    J ECT; 2013 Sep; 29(3):162-9. PubMed ID: 23609520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Association Between Electrical Stimulation Dose, Subsequent Cognitive Function and Depression Severity in Patients Receiving Bilateral Electroconvulsive Therapy for Major Depressive Disorder.
    Sinclair JE; Fernie G; Bennett DM; Reid IC; Cameron IM
    J ECT; 2016 Sep; 32(3):159-63. PubMed ID: 27128722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
    Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
    J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study.
    Belge JB; van Diermen L; Sabbe B; Parizel P; Morrens M; Coppens V; Constant E; de Timary P; Sienaert P; Schrijvers D; van Eijndhoven P
    Neuropsychobiology; 2020; 79(3):222-232. PubMed ID: 32114575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive function in treatment-resistant depression before and after electroconvulsive therapy.
    Stojanovic Z; Andric S; Soldatovic I; Dolic M; Spiric Z; Maric NP
    World J Biol Psychiatry; 2017 Dec; 18(8):624-632. PubMed ID: 27072874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and Cognitive Functioning in Depressed Older Adults Treated With Electroconvulsive Therapy: A Prospective Cohort Study.
    Carlier A; Rhebergen D; Veerhuis R; Schouws S; Oudega ML; Eikelenboom P; Bouckaert F; Sienaert P; Obbels J; Stek ML; van Exel E; Dols A
    J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34383393
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8.
    Kruse JL; Olmstead R; Hellemann G; Wade B; Jiang J; Vasavada MM; Brooks Iii JO; Congdon E; Espinoza R; Narr KL; Irwin MR
    Brain Behav Immun; 2020 Oct; 89():59-66. PubMed ID: 32479994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis.
    Gay F; Romeo B; Martelli C; Benyamina A; Hamdani N
    Psychiatry Res; 2021 Mar; 297():113735. PubMed ID: 33497973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.
    Maier H; Helm S; Toto S; Moschny N; Sperling W; Hillemacher T; Kahl KG; Jakubovski E; Bleich S; Frieling H; Neyazi A
    Dis Markers; 2018; 2018():2358451. PubMed ID: 29545905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
    Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
    Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study.
    Strandberg P; Nordenskjöld A; Bodén R; Ekman CJ; Lundberg J; Popiolek K
    J ECT; 2024 Jun; 40(2):88-95. PubMed ID: 38048154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.